Vera Bank, N.A. Eli Lilly & CO Transaction History

Vera Bank, N.A.

$310 Million
Q2 2024

A detailed history of Vera Bank, N.A. transactions in Eli Lilly & CO stock. As of the latest transaction made, Vera Bank, N.A. holds 3,669 shares of LLY stock, worth $3.25 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares

3,669

Previous 3,679 0.27%

Holding current value

$3.25 Million

Previous $2.86 Million 16.04%

% of portfolio

1.07%

Previous 0.93%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$724.87 - $909.04 $7,248 - $9,090	-10 Reduced 0.27%	3,669 $3.32 Million
Q1 2024 May 03, 2024	SELL	$592.2 - $792.28 $86,461 - $115,672	-146 Reduced 3.82%	3,679 $2.86 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $40,964 - $48,292	78 Added 2.08%	3,825 $2.23 Million
Q3 2023 Oct 24, 2023	BUY	$434.7 - $599.3 $30,429 - $41,951	70 Added 1.9%	3,747 $2.01 Million
Q1 2023 Apr 20, 2023	SELL	$310.63 - $364.82 $9,940 - $11,674	-32 Reduced 0.86%	3,677 $1.26 Million
Q2 2022 Jul 28, 2022	SELL	$278.73 - $327.27 $9,476 - $11,127	-34 Reduced 0.91%	3,709 $1.2 Million
Q1 2022 Apr 27, 2022	SELL	$234.69 - $291.66 $9,152 - $11,374	-39 Reduced 1.03%	3,743 $1.07 Million
Q4 2021 Feb 04, 2022	BUY	$224.85 - $279.04 $53,064 - $65,853	236 Added 6.66%	3,782 $1.05 Million
Q3 2021 Oct 07, 2021	BUY	$221.6 - $272.71 $19,500 - $23,998	88 Added 2.54%	3,546 $819,000
Q2 2021 Aug 04, 2021	BUY	$180.55 - $233.54 $10,471 - $13,545	58 Added 1.71%	3,458 $794,000
Q1 2020 Apr 21, 2020	BUY	$119.05 - $147.35 $178,575 - $221,025	1,500 Added 78.95%	3,400 $472,000
Q4 2019 Jan 27, 2020	BUY	$106.92 - $132.43 $203,148 - $251,617	1,900 New	1,900 $250,000

Others Institutions Holding LLY

# of Institutions

3,871

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $843B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vera Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Vera Bank, N.A. with notifications on news.

Account